Ebola from Bedside to Bench.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31150616.
- Also identified by DOI 10.1016/j.cell.2019.05.021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A longitudinal study by Davis et al. followed the evolution of antibody responses in four survivors of the 2014 Ebola outbreak treated in the United States and provides insight into the emergence of neutralizing antibodies long after convalescence.
Medical subject headings
- Ebolavirus
- Hemorrhagic Fever, Ebola